The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Effect of nicotine and nicotinic receptors on anxiety and depression
Abstract
Nicotine has been shown to have effects on anxiety and depression in both human and animal studies. These studies suggest that nicotinic acetylcholine receptors (nAChRs) can modulate the function of pathways involved in stress response, anxiety and depression in the normal brain, and that smoking can result in alterations of anxiety level and mood. The effects of nicotine are complex however, and nicotine treatment can be either anxiolytic or anxiogenic depending on the anxiety model tested, the route of nicotine administration and the time course of administration. The paradoxical effects of nicotine on emotionality are likely due to the broad expression of nAChRs throughout the brain, the large number of nAChR subtypes that have been identified and the ability of nicotine treatment to both activate and desensitize nAChRs. Activation of nAChRs has been shown to modulate many systems associated with stress response including stress hormone pathways, monoaminergic transmission and release of classical neurotransmitters throughout the brain. Local administration studies in animals have identified brain areas that may be involved in the anxiogenic and anxiolytic actions of nicotine including the lateral septum, the dorsal raphe nuclei, the mesolimbic dopamine system and the hippocampus. The ensemble of studies to date suggest that under certain conditions nicotine can act as an anxiolytic and an antidepressant, but that following chronic use, adaptations to nicotine can occur resulting in increased anxiety and depression following withdrawal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, a large proportion of smokers report that they smoke to control symptoms of anxiety and depression (Picciotto et al. 2002), and the rate of smoking in individuals with affective disorders is more than double the rate in the general population (Kalman et al. 2005).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Picciotto et al. 2002
In the citing paper
“However, the elevated-zero maze has been found to yield diverse and conflicting results with nicotinic compounds (Picciotto et al., 2002).”
From Nicotinic Partial Agonists Varenicline and Sazetidine-A Have Differential Effects on Affective Behavior (2010) · cites this paper as Picciotto et al., 2002
In the citing paper
“At the behavioral level, nicotine's effects on DRN neurons mediate anxiogenic and anxiolytic effects following nicotine administration and during nicotine withdrawal (Cheeta et al., 2001; Picciotto et al., 2002).”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Picciotto et al., 2002
In the citing paper
“Clinical data on the role of nicotine in anxiety is more complex, with the most consistent findings being the development of anxiety symptoms in the context of withdrawal, and the observation that these symptoms may improve with nicotine replacement (Picciotto et al., 2002).”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Picciotto et al., 2002
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585
Peto, R., Darby, S., Deo, H., Silcocks, P., Whitley, E., & Doll, R. (2000) · British medical journal · doi:10.1136/bmj.321.7257.323 · Cited by 1,504
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
Crawley, J. N., & Goodwin, F. K. (1980) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(80)90067-2 · Cited by 1,432
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Self-citationNicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070
Life course outcomes of young people with anxiety disorders in adolescence
WOODWARD, L. J., & FERGUSSON, D. M. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200109000-00018 · Cited by 1,051
Wada, E., Wada, K., Boulter, J., Deneris, E. S., Heinemann, S., Patrick, J., & Swanson, L. W. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902840212 · Cited by 1,044
A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat
Vertes, R. P. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903130409 · Cited by 842
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829
File, S. E. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90012-6 · Cited by 820
Smoking and Major Depression: A Causal Analysis
Kendler, K. S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130038007 · Cited by 792
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674
Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain
Picciotto, M. R., Zoli, M., Léna, C., Bessis, A., Lallemand, Y., LeNovère, N., Vincent, P., Pich, E. M., Brûlet, P., & Changeux, J.-P. (1995) · Nature · doi:10.1038/374065a0 · Cited by 668
Self-citationMajor Depression and Stages of Smoking
Breslau, N., Peterson, E. L., Schultz, L. R., Chilcoat, H. D., & Andreski, P. M. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.161 · Cited by 650
Orr‐Urtreger, A., Göldner, F. M., Saeki, M., Lorenzo, I., Goldberg, L. B., Biasi, M. D., Dani, J. A., Patrick, J. W., & Beaudet, A. L. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09165.1997 · Cited by 494
The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety
Davis, M. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90014-w · Cited by 427
Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period
Erb, S. M., Shaham, Y., & Stewart, J. (1996) · Psychopharmacology · doi:10.1007/s002130050150 · Cited by 406
Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04461.1998 · Cited by 404
Self-citationFunctional contributions of α5 subunit to neuronal acetylcholine receptor channels
Ramírez-Latorre, J. A., Yu, C., Qu, X., Perin, F., Karlin, A., & Role, L. W. (1996) · Nature · doi:10.1038/380347a0 · Cited by 395
Psychiatric comorbidity of smoking and nicotine dependence
Breslau, N. (1995) · Behavior Genetics · doi:10.1007/bf02196920 · Cited by 391
Identification of four classes of brain nicotinic receptors using beta2 mutant mice.
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · PubMed Central · doi:10.1523/jneurosci.18-12-04461.1996 · Cited by 387
Self-citationLe Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385
The Flinders sensitive line rats: a genetic animal model of depression
Overstreet, D. H. (1993) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80230-1 · Cited by 369
Grady, S., Marks, M. J., Wonnacott, S., & Collins, A. C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08322.x · Cited by 350
Zoli, M., Novère, N. G. L., Hill, J. A., & Changeux, J. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01912.1995 · Cited by 337
Intravenous nicotine in Alzheimer's disease: a pilot study
NEWHOUSE, P. A., Sunderland, T., Tariot, P. N., Blumhardt, C. L., Weingartner, H., Mellow, A. M., & Murphy, D. L. (1988) · Psychopharmacology · doi:10.1007/bf00174504 · Cited by 308
Role of the amygdala and periaqueductal gray in anxiety and panic.
Graeff, F. G., Silveira, M. C. L., Nogueira, R. L., Audi, E. A., & Oliveira, R. M. W. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90097-a · Cited by 301
Paylor, R., Nguyen, M., Crawley, J. N., Patrick, J., Beaudet, A., & Orr-Urtreger, A. (1998) · Learning & Memory · doi:10.1101/lm.5.4.302 · Cited by 298
Marshall, D. L., Redfern, P. H., & Wonnacott, S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68041511.x · Cited by 284
Fryer, J. D., & Lukas, R. J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37928-5 · Cited by 283
Clarke, P. B. S., & Reuben, M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15232.x · Cited by 262
The effect of bupropion on nicotine craving and withdrawal
Shiffman, S., Johnston, J. A., Khayrallah, M., Elash, C. A., Gwaltney, C. J., Paty, J. A., Gnys, M., Evoniuk, G., & DeVeaugh-Geiss, J. (2000) · Psychopharmacology · doi:10.1007/s002130050022 · Cited by 259
Wada, E., McKinnon, D. H., Heinemann, S., Patrick, J., & Swanson, L. W. (1990) · Brain Research · doi:10.1016/0006-8993(90)90248-a · Cited by 254
Social stress increases the acquisition of cocaine self-administration in male and female rats
Haney, M., Maccari, S., Moal, M. L., Simon, H., & Piazza, P. V. (1995) · Brain Research · doi:10.1016/0006-8993(95)00788-r · Cited by 250
The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam.
Graeff, F. G., Viana, M. D. B., & Tomaz, C. A. B. (1993) · PubMed · Cited by 245
The Role of the Dorsal Hippocampal Serotonergic and Cholinergic Systems in the Modulation of Anxiety
File, S. E., Kenny, P. J., & Cheeta, S. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00198-2 · Cited by 239
Acquisition of cocaine self-administration after social stress: role of accumbens dopamine
Tidey, J. W., & Miczek, K. A. (1997) · Psychopharmacology · doi:10.1007/s002130050230 · Cited by 236
Human α6 AChR subtypes: subunit composition, assembly, and pharmacological responses
Kuryatov, A., Olale, F., Cooper, J., Choi, C. H., & Lindstrom, J. M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00144-1 · Cited by 224
Immunocytochemical localization of a neuronal nicotinic receptor: the beta 2-subunit
Hill, J., Zoli, M., Bourgeois, J., & Changeux, J. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01551.1993 · Cited by 220
Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test
Brioni, J. D., O'Neill, A. B., Kim, D. J. B., & Decker, M. W. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90498-7 · Cited by 216
Kinnunen, T., Doherty, K., Militello, F. S., & Garvey, A. J. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.4.791 · Cited by 212
Antidepressant effects of nicotine in an animal model of depression
Tizabi, Y., Overstreet, D. H., Rezvani, A. H., Louis, V. A., Clark Jr, E., Janowsky, D. S., & Kling, M. A. (1999) · Psychopharmacology · doi:10.1007/s002130050879 · Cited by 209
Increased neurodegeneration during ageing in mice lacking high‐affinity nicotine receptors
Zoli, M., Picciotto, M. R., Ferrari, R., Cocchi, D., & Changeux, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1235 · Cited by 208
Self-citationDepression – emerging insights from neurobiology
Vaidya, V. A., & Duman, R. S. (2001) · British Medical Bulletin · doi:10.1093/bmb/57.1.61 · Cited by 206
Ross, S. A., Wong, J. Y. F., Clifford, J. J., Kinsella, A., Massalas, J. S., Horne, M. K., Scheffer, I. E., Kola, I., Waddington, J. L., Berkovic, S. F., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06431.2000 · Cited by 204
Chapter 15 Presynaptic modulation of transmitter release by nicotinic receptors
Wonnacott, S., Irons, J., RAPIER, C. M., Thorne, B., & Lunt, G. G. (1989) · Progress in brain research · doi:10.1016/s0079-6123(08)62475-9 · Cited by 200
Comorbidity Between Depressive Disorders and Nicotine Dependence in a Cohort of 16-Year-Olds
Fergusson, D. M. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830110081010 · Cited by 200
File, S. E., Kenny, P. J., & Ouagazzal, A. (1998) · Behavioral Neuroscience · doi:10.1037//0735-7044.112.6.1423 · Cited by 193
Activational effects of social stress on IV cocaine self-administration in rats
Miczek, K. A., Mutschler, N. H., & Mizcek, K. A. (1996) · Psychopharmacology · doi:10.1007/s002130050133 · Cited by 192
Briggs, C., Anderson, D. J., Brioni, J., Buccafusco, J., Buckley, M., Campbell, J. E., Decker, M. W., Donnelly-Roberts, D., Elliott, R., Gopalakrishnan, M., et al. (1997) · Pharmacology, Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00354-1 · Cited by 190
The actions of nicotine and cocaine in a mouse model of anxiety
Costall, B., Elizabeth Kelly, M., Naylor, R. J., & Onaivi, E. S. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90450-4 · Cited by 186
Feldman, S., Conforti, N., & Weidenfeld, J. (1995) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)00062-6 · Cited by 184
Cooper, B. R., Wang, C. M., Cox, R. F., Norton, R. M., Shea, V., & Ferris, R. M. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.43 · Cited by 183
Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons
Léna, C., d’Exaerde, A. D. K., Cordero‐Erausquin, M., Novère, N. G. L., Jiménez, M. D. M. A., & Changeux, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12126 · Cited by 181
Labarca, C., Schwarz, J., Deshpande, P., Schwarz, S., Nowak, M. W., Fonck, C., Nashmi, R., Kofuji, P., Dang, H., Shi, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041582598 · Cited by 177
Gilbert, D. G., Robinson, J. H., Chamberlin, C. L., & Spielberger, C. D. (1989) · Psychophysiology · doi:10.1111/j.1469-8986.1989.tb01924.x · Cited by 167
Kenny, P. J., File, S. E., & Rattray, M. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00246-1 · Cited by 165
(1996) · PubMed · Cited by 156
Grady, S. R., Meinerz, N. M., Cao, J., Reynolds, A. M., Picciotto, M. R., Changeux, J., McIntosh, J. M., Marks, M. J., & Collins, A. C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00019.x · Cited by 156
Wilkins, J., Carlson, H., van Vunakis, H., Hill, M., Gritz, E., & Jarvik, M. (1982) · Psychopharmacology · doi:10.1007/bf00433730 · Cited by 155
Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders
Diwan, A., Castine, M., Pomerleau, C. S., Meador-Woodruff, J. H., & Dalack, G. W. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00045-0 · Cited by 152
Nicotine enhancement of contextual fear conditioning
Gould, T. J., & Wehner, J. M. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(98)00157-0 · Cited by 151
Role of Corticosterone in Intravenous Cocaine Self-Administration in Rats
Goeders, N. E., & Guerin, G. F. (2008) · Neuroendocrinology · doi:10.1159/000127137 · Cited by 151
Neuroendocrine actions of nicotine and of exposure to cigarette smoke: Medical implications
Fuxé, K., Andersson, K., Eneroth, P. H. E., Härfstrand, A., & Agnati, L. F. (1989) · Psychoneuroendocrinology · doi:10.1016/0306-4530(89)90054-1 · Cited by 147
Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats
Semba, J., Mataki, C., Yamada, S., Nankai, M., & Toru, M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00477-0 · Cited by 140
Response of the hypothalamo-pituitary-adrenal axis to nicotine
Matta, S. G., Fu, Y., Valentine, J. D., & Sharp, B. M. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00079-6 · Cited by 139
Antidepressants Noncompetitively Inhibit Nicotinic Acetylcholine Receptor Function
Fryer, J. D., & Lukas, R. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721117.x · Cited by 137
French, S. J., Humby, T., Horner, C. H., Sofroniew, M. V., & Rattray, M. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00048-0 · Cited by 134
Lü, Y., Grady, S. R., Marks, M. J., Picciotto, M. R., Changeux, J., & Collins, A. C. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37839-5 · Cited by 129
Self-citationDissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions.
Treit, D., & Menard, J. L. (1997) · Behavioral Neuroscience · doi:10.1037//0735-7044.111.3.653 · Cited by 128
Low platelet monoamine oxidase activity in cigarette smokers
Oreland, L., Fowler, C. J., & Schalling, D. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90706-2 · Cited by 128
Ouagazzal, A.-M., Kenny, P. J., & File, S. E. (1999) · Psychopharmacology · doi:10.1007/s002130050976 · Cited by 121
Common aspects of the action of nicotine and other drugs of abuse
Picciotto, M. R. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00074-x · Cited by 117
Self-citationFile, S. E., Gonzalez, L. E., & Andrews, N. (1998) · Behavioral Neuroscience · doi:10.1037//0735-7044.112.2.352 · Cited by 115
Cheeta, S., Irvine, E. E., Kenny, P. J., & File, S. E. (2001) · Psychopharmacology · doi:10.1007/s002130100681 · Cited by 113
Functional α6-Containing Nicotinic Receptors Are Present in Chick Retina
Vailati, S., Hanke, W. R. L., Bejan, A., Barabino, B., Longhi, R., Balestra, B., Moretti, M., Clementi, F., & Gotti, C. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.11 · Cited by 111
Neurobiological mechanisms by which nicotine mediates different types of anxiety
File, S. E., Cheeta, S., & Kenny, P. J. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00889-4 · Cited by 110
Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse
Costall, B., Jones, B. J., Kelly, M. E., Naylor, R. J., Onaivi, E. S., & Tyers, M. B. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90414-d · Cited by 109
REVIEW Nesbitt's Paradox resolved? Stress and arousal modulation during cigarette smoking
Parrott, A. C. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.931274.x · Cited by 107
Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions.
Treit, D., & Menard, J. L. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.3.653 · Cited by 104
Tsuneki, H., Klink, R., Léna, C., Korn, H., & Changeux, J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00138.x · Cited by 100
Fu, Y.-T., Matta, S. G., James, T. J., & Sharp, B. M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37341-0 · Cited by 92
(S)‐3‐メチル‐5‐(1‐メチル‐2‐ピロリジニル)イソキサゾール(ART418) 認知促進および抗不安活性を持つ新しいコリン作動性リガンド II in vivoの性質
Decker, M. W., Brioni, J. D., Sullivan, J. P., et al. (1994) · Journal of Pharmacology and Experimental Therapeutics · Cited by 92
Canfield, D. R., Spealman, R. D., Kaufman, M. J., & Madras, B. K. (1990) · Synapse · doi:10.1002/syn.890060211 · Cited by 91
Irvine, E. E., Cheeta, S., & File, S. E. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199911000-00016 · Cited by 89
Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal
Irvine, E. E., Cheeta, S., & File, S. E. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00449-4 · Cited by 88
Nicotine elevates rat plasma ACTH by a central mechanism.
Matta, S. G., BEYER, H. S., McAllen, K., & Sharp, B. M. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39223-2 · Cited by 87
Latency to enter a mirrored chamber: A novel behavioral assay for anxiolytic agents
Toubas, P. L., Abla, K. A., Cao, W., et al. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90215-4 · Cited by 87
Novère, N. G. L., Zoli, M., Léna, C., Ferrari, R., Picciotto, M. R., Merlo‐Pich, E., & Changeux, J. (1999) · Neuroreport · doi:10.1097/00001756-199908200-00012 · Cited by 86
Self-citationCortisol response to a psychological stressor and/or nicotine
Pomerleau, O. F., & Pomerleau, C. S. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90153-9 · Cited by 86
Ferguson, S. M., Brodkin, J. D., Kenneth Lloyd, G., & Menzaghi, F. (2000) · Psychopharmacology · doi:10.1007/s002130000531 · Cited by 85
Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors
Decker, M. W., Anderson, D. J., Brioni, J. D., Donnelly‐Roberts, D. L., Kang, C. H., O'Neill, A. B., Piattoni-Kaplan, M., Swanson, S. T., & Sullivan, J. P. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00191-m · Cited by 84
Lapchak, P. A., Araujo, D. M., & Hefti, F. F. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90407-7 · Cited by 82
Smoking Cessation Leads to Reduced Stress, but Why?
Parrott, A. C. (1995) · International Journal of the Addictions · doi:10.3109/10826089509055846 · Cited by 82
Barazangi, N., & Role, L. W. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.1.463 · Cited by 81
Andersson, K., Siegel, R. A., Fuxé, K., et al. (1983) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1983.tb07237.x · Cited by 79
Antidepressant Effect of Ingested Nicotine in Female Rats of Flinders Resistant and Sensitive Lines
Djurić, V. J., Dunn, E., Overstreet, D. H., Dragomir, A., & Steiner, M. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00091-8 · Cited by 79
Anxiolytic-like effects of the novel cholinergic channel activator ABT-418
Brioni, J. D., O'Neill, A. B., Kim, D. J., Buckley, M. J., Decker, M. W., & Arneric, S. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22796-3 · Cited by 77
A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber
Cao, W., Burkholder, T., Wilkins, L. H., & Collins, A. C. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90124-c · Cited by 76
Depression and nicotine: preclinical and clinical evidence for common mechanisms
Laje, R. P., Berman, J. A., & Glassman, A. H. (2001) · Current Psychiatry Reports · doi:10.1007/s11920-001-0040-z · Cited by 74
Sharp, B. M., & Matta, S. G. (1993) · Endocrinology · doi:10.1210/endo.133.1.8391419 · Cited by 74
Irvine, E. E., Bagnalasta, M., Marcon, C., Motta, C., Tessari, M., File, S. E., & Chiamulera, C. (2000) · Psychopharmacology · doi:10.1007/s002130000586 · Cited by 73
Stimulation of nicotinic receptors in the lateral septal nucleus increases anxiety
Ouagazzal, A., Kenny, P. J., & File, S. E. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00823.x · Cited by 72
Sensitization to Stress and Psychostimulants
Prasad, B. M., Sorg, B. A., Ulibarri, C., & Kalivas, P. W. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44714.x · Cited by 71
Social isolation modifies nicotine's effects in animal tests of anxiety
Cheeta, S., Irvine, E., & File, S. E. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703991 · Cited by 71
Depressive Characteristics of FSL Rats
Tizabi, Y., Rezvani, A. H., Russell, L. T., Tyler, K. Y., & Overstreet, D. H. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00236-7 · Cited by 70
Smythe, J. W., Bhatnagar, S., Murphy, D., Timothy, C., & Costall, B. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00311-0 · Cited by 68
Fu, Y., Matta, S. G., Brower, V. G., & Sharp, B. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-22-08979.2001 · Cited by 66
Nakamura, K. T., & Kurasawa, M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01005-6 · Cited by 65
Nicotine regulates 5‐HT1A receptor gene expression in the cerebral cortex and dorsal hippocampus
Kenny, P. J., File, S. E., & Rattray, M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01501.x · Cited by 63
Conditioned tolerance to the anorectic and corticosterone-elevating effects of nicotine
Caggiula, A. R., Epstein, L. H., Antelman, S. M., Saylor, S., Perkins, K. A., Knopf, S., & Stiller, R. L. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90319-w · Cited by 63
Kenny, P. J., Cheeta, S., & File, S. E. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00114-8 · Cited by 63
George, T. P., Verrico, C. D., Picciotto, M. R., & Roth, R. H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38869-x · Cited by 62
Self-citationCrawley, J. N., Marangos, P. J., Paul, S. M., et al. (1981) · Science · doi:10.1126/science.6256859 · Cited by 62
Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice
Zarrindast, M., Homayoun, H., Babaie, A., Etminani, A., & Gharib, B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00628-2 · Cited by 61
Gäddnäs, H., Pietilä, K., & Ahtee, L. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00201-1 · Cited by 60
Olausson, P., Engel, J. A., & Söderpalm, B. (1999) · Psychopharmacology · doi:10.1007/s002130050869 · Cited by 59
Male-female differences in rat hypothalamic-pituitary-adrenal axis responses to nicotine stimulation
Rhodes, M. E., O’Toole, S. M., Czambel, R. K., & Rubin, R. T. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00488-9 · Cited by 58
Inhibition of neuronal nicotinic acetylcholine receptors by imipramine and desipramine
Rana, B., McMorn, S. O., Reeve, H. L., Wyatt, C. N., Vaughan, P. F. T., & Peers, C. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90388-x · Cited by 57
Rat brain monoamine oxidase A and B inhibitory (tribulin) activity during drug withdrawal anxiety
Bhattacharya, S. K., Chakrabarti, A., Sandler, M., et al. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12032-y · Cited by 52
Balfour, D. J. K., Graham, C. A., & Vale, A. L. (1986) · Psychopharmacology · doi:10.1007/bf00174073 · Cited by 52
Fu, Y., Matta, S. G., Valentine, J. D., & Sharp, B. M. (1997) · Endocrinology · doi:10.1210/endo.138.5.5122 · Cited by 51
Cheeta, S., Kenny, P. J., & File, S. E. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00246.x · Cited by 50
López, A. D. (1998) · BMJ · doi:10.1136/bmj.317.7170.1399 · Cited by 48
Adrenocortical hormone regulation of nicotine sensitivity in mice
Pauly, J. R., Ullman, E. A., & Collins, A. C. (1988) · Physiology & Behavior · doi:10.1016/0031-9384(88)90353-8 · Cited by 48
Corticosterone-attenuating and anxiolytic properties of mecamylamine in the rat
Newman, M. B., Nazian, S. J., Sanberg, P. R., Diamond, D. M., & Shytle, R. D. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00178-0 · Cited by 47
Benzodiazepines, putative anxiolytics and animal models of anxiety
Green, S. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90070-b · Cited by 47
Olausson, P., Åkesson, P., Engel, J. A., & Söderpalm, B. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00939-6 · Cited by 46
George, T. P., Verrico, C. D., & Roth, R. H. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00537-x · Cited by 43
Szyndler, J., Sienkiewicz‐Jarosz, H., Maciejak, P., Siemiątkowski, M., Rokicki, D., Członkowska, A., & Płaźnik, A. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00548-2 · Cited by 42
Vale, A. L., & Green, S. (1996) · Behavioural Pharmacology · doi:10.1097/00008877-199603000-00004 · Cited by 40
Lu, Y., Marks, M. J., & Collins, A. C. (1999) · PubMed · Cited by 39
Association study of nicotinic-receptor variants and major depressive disorder
Lai, I., Hong, C., & Tsai, S. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00292-5 · Cited by 39
Serova, L., Danailov, E., Chamas, F., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35180-8 · Cited by 39
Benzodiazepine receptor mediation of the anxiolytic-like effect of (−)-nicotine in mice
O'Neill, A. B., & Brioni, J. D. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90097-3 · Cited by 38
Caggiula, A. R., Epstein, L. H., Antelman, S. M., Saylor, S., Knopf, S., Perkins, K. A., & Stiller, R. L. (1993) · Psychopharmacology · doi:10.1007/bf02253543 · Cited by 38
Picciotto, M. R., Zoli, M., Zachariou, V., & Changeux, J. (1997) · Biochemical Society Transactions · doi:10.1042/bst0250824 · Cited by 35
Self-citationCHOLINERGIC DYSFUNCTION IN DEPRESSION
Janowsky, D. S., & Overstreet, D. H. (1990) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1990.tb02077.x · Cited by 33
George, T. P. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00165-7 · Cited by 30
Dependence on Smoking and the Acoustic Startle Response in Healthy Smokers
Mueller, V., Mucha, R. F., & Pauli, P. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00508-x · Cited by 27
Adrenalectomy attenuates nicotine-induced dopamine release and locomotor activity in rats
Shoaib, M., & Shippenberg, T. S. (1996) · Psychopharmacology · doi:10.1007/s002130050143 · Cited by 27
Behavioural and neural-system analyses of the actions of anxiolytic drugs
Gray, J. A. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90203-1 · Cited by 27
Involvement of amygdalar alpha adrenoceptors in hypothalamo-pituitary-adrenocortical responses
Feldman, S., & Weidenfeld, J. (1996) · Neuroreport · doi:10.1097/00001756-199611250-00052 · Cited by 26
Ericson, M., Olausson, P., Engel, J. A., & Söderpalm, B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00191-6 · Cited by 26
Strain differences in adrenalectomy-induced alterations in nicotine sensitivity in the mouse
Pauly, J. R., Ullman, E. A., & Collins, A. C. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90223-5 · Cited by 26
Nicotine activates NPY and catecholaminergic neurons in brainstem regions involved in ACTH secretion
Matta, S. G., Valentine, J. D., & Sharp, B. M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00266-7 · Cited by 26
Repeated cocaine and stress increase dopamine clearance in the rat medial prefrontal cortex
Meiergerd, S. M., Schenk, J. O., & Sorg, B. A. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00926-8 · Cited by 25
Chronic injections of saline produce subsensitivity to nicotine
Flemmer, D. D., & Dilsaver, S. C. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90309-2 · Cited by 24
Köfalvi, A., Sperlaágh, B., Zelles, T., & Vizi, E. S. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38926-8 · Cited by 21
Novick, L. F. (2000) · Journal of Public Health Management and Practice · doi:10.1097/00124784-200006030-00001 · Cited by 20
George, T. P., Picciotto, M. R., Verrico, C. D., & Roth, R. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00928-8 · Cited by 18
Self-citationYamanashi, K., Miyamae, T., Misu, Y., et al. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01174-8 · Cited by 17
Tolerance to midazolam's anxiolytic effects after short-term nicotine treatment
Irvine, E. E., Cheeta, S., Lovelock, C., & File, S. E. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00211-2 · Cited by 17
Andersson, K., Fuxé, K., Eneroth, P. H. E., Jansson, A., & H�rfstrand, A. (1989) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00736052 · Cited by 16
Kasckow, J., Regmi, A., Sheriff, S., Mulchahey, J. J., & Geracioti, T. D. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00539-1 · Cited by 15
Effect of chronic (-)-nicotine treatment on rat cerebral benzodiazepine receptors
Magata, Y., Kitano, H., Shiozaki, T., et al. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00078-5 · Cited by 14
Research works printed but not linked: 18
- 1988, Washington: US Government Printing Office, &NA;
- Pomerleau, 1986, Psychopharm Bull, 22, 865
- Kinnunen, 1996, J Consult Clin Psychol, 64, 791, 10.1037/0022-006X.64.4.791 · DOI
- Lu, 1999, J Pharmacol Exp Ther, 291, 1127
- Lu, 1998, J Pharmacol Exp Ther, 287, 648
- File, 1998, Behav Neurosci, 112, 1423, 10.1037/0735-7044.112.6.1423 · DOI
- Brioni, 1994, J Pharm Exp Ther, 271, 353
- File, 1998, Behav Neurosci, 112, 352, 10.1037/0735-7044.112.2.352 · DOI
- Decker, 1994, J Pharmacol Exp Ther, 270, 319
- Salin-Pascual, 1996, J Clin Psychiatry, 57, 387
- Fryer, 1999, J Pharmacol Exp Ther, 288, 88
- Matta, 1987, J Pharm Exp Ther, 243, 217
- Fu, 1998, J Pharmacol Exp Ther, 284, 1188
- Engberg, 2000, Naunyn Schmeiders Arch Pharmacol, 362, 41
- George, 2000, J Pharm Exp Ther, 295, 58
- Kofalvi, 2000, J Pharmacol Exp Ther, 295, 453
- Serova, 1999, J Pharmacol Exp Ther, 291, 884
- Graeff, 1993, Braz J Med Biol Res, 26, 67
Cited by
Sorted by citations
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.036 · Cited by 1,404
Self-citationSmoking and mental illness: results from population surveys in Australia and the United States
Lawrence, D., Mitrou, F., & Zubrick, S. R. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-285 · Cited by 517
Sleep and anxiety: From mechanisms to interventions
Chellappa, S. L., & Aeschbach, D. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101583 · Cited by 509
Belmonte, M. K., Cook, E. H., Anderson, G. M., Rubenstein, J. L. R., Greenough, W. T., Beckel-Mitchener, A., Courchesne, E., Boulanger, L. M., Powell, S. B., Levitt, P. R., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001499 · Cited by 442
Smoking and the Five‐Factor Model of personality
Terracciano, A., & Costa, P. T. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00687.x · Cited by 422
Metadata
- Authors
- Picciotto, M. R., Brunzell, D. H., & Caldarone, B. J.
- Affiliations
- Yale University (US)
- Venue
- Neuroreport
- Published
- 2002-07
- Volume
- 13
- Issue
- 9
- Pages
- 1097-1106
- ISSN
- 0959-4965 (ISSN-L)
- OpenAlex
- W2080934698
- Cited by
- 483
- References
- 161
- Citations by year
- 2026: 9 · 2025: 24 · 2024: 25 · 2023: 24 · 2022: 19 · 2021: 24 · 2020: 20 · 2019: 17 · 2018: 16 · 2017: 18 · 2016: 16 · 2015: 28 · 2014: 27 · 2013: 30 · 2012: 30
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroreport (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA14241, DA84733, DA 00436)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nicotine, nicotinic acetylcholine receptors, anxiety, depression, anxiolytic effects, anxiogenic effects, stress response, nicotine withdrawal, receptor desensitization, monoaminergic transmission, lateral septum, dorsal raphe nucleus, mesolimbic dopamine system, hippocampus, smoking
- MeSH terms
- Animals, Anxiety, Brain, Brain Chemistry, Depression, Humans, Neural Pathways, Nicotine, Receptors, Nicotinic, Stress, Physiological, Tobacco Use Disorder, Neurotransmitter Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
